First human tests begin for new drug candidate
NCT ID NCT06575400
Summary
This is an early-stage study to check the safety and how the body processes a new drug called BI 3804379. It involves 106 healthy adult volunteers who will receive either the drug or a placebo. The main goal is to see how well the drug is tolerated and how it moves through the body at different doses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
SGS Life Science Services - Clinical Research
RECRUITINGEdegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.